How many institutions held SLDB - Solid Biosciences Inc. - Common Stock, $0.001 par value per share in Q4 2022?

30 institutional investors reported SLDB - Solid Biosciences Inc. - Common Stock, $0.001 par value per share for Q4 2022. Use the holders table for investor-level position and value details.

Solid Biosciences Inc. - Common Stock, $0.001 par value per share (SLDB)

Q: What does CUSIP 83422E204 represent in this 13F holders report?

CUSIP 83422E204 is the security identifier for SLDB - Solid Biosciences Inc. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

CUSIP: 83422E204

Q4 2022 13F Holders as of 31 Dec 2022

Security type / class: Equity / Common Stock, $0.001 par value per share
Shares outstanding: 92,783,558
Total 13F shares: 15,014,401
Share change: +15,014,401
Total reported value: $80,763,090
Reported price per share: $5.38
Number of holders: 30
Value change: +$80,763,090
Number of buys: 30

Security key

83422E204

Report period

Q4 2022

Institutions

Top holders

SLDB full security history Ownership snapshot Full 13F holder table Newer quarter: Q1 2023 Previous quarter: Q4 2020 Solid Biosciences Inc. SEC filings Solid Biosciences Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 83422E204

Newer quarter: Q1 2023 Previous quarter: Q4 2020

Recent filing periods:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Ownership snapshot

Top reported holders of SLDB - Solid Biosciences Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder

PERCEPTIVE ADVISORS LLC

13D/G signal

—

Evidence rows

Latest as of

30 Sep 2022

13F Lead comparable stake: 13% Showing 1-6 of 15 holder rows.

Rank 1 holder

PERCEPTIVE ADVISORS LLC

13F

Ownership: 13%
Position: $6.26M

13F

Rank 2 holder

RA CAPITAL MANAGEMENT, L.P.

13F

Ownership: 12%
Position: $5.77M

13F

Rank 3 holder

Alyeska Investment Group, L.P.

13F

Ownership: 8%
Position: $3.74M

13F

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
PERCEPTIVE ADVISORS LLC	13F Company 13F	13%	$6,258,000 13,412,552 shares	—	30 Sep 2022
RA CAPITAL MANAGEMENT, L.P.	13F Company 13F	12%	$5,771,000 12,367,873 shares	—	30 Sep 2022
Alyeska Investment Group, L.P.	13F Company 13F	8%	$3,738,000 8,102,223 shares	—	30 Sep 2022
Bain Capital Life Sciences Investors, LLC	13F Company 13F	7.9%	$3,700,000 7,929,918 shares	—	30 Sep 2022
K2 PRINCIPAL FUND, L.P.	13F Company 13F	5.5%	$2,478,000 5,561,236 shares	—	30 Sep 2022
VANGUARD GROUP INC	13F Company 13F	3.3%	$1,558,000 3,339,156 shares	—	30 Sep 2022

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

15,014,401

Rows available

Investor	Option	Weight %	Change %	Reported value	* Price	Shares	Share Change	Activity	Report Period

^* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q4 2022 vs Q4 2020 Across Filers

Q4 2020 holders

Q4 2022 holders

Holder diff

Investor	Q4 2020 Shares	Q4 2022 Shares	Share Diff	Share Chg %	Q4 2020 value	Q4 2022 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend